About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Growth of Healthy Term Infants Fed Formula Containing DHA-B

Growth of Healthy Term Infants Fed Formula Containing DHA-B

NCT02144402·10 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

dsm-firmenich Switzerland AG

With

Accelovance

Age

0–0

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

full term infant (gestational age 37-42 weeks)
birth weight \> or equal to 2500 g
singleton infant \< or equal to 14 days of age in good health
parent must be \>21 years of age
parental consent

You may not be if

congenital malformation or genetic disorder
metabolic anomalies
maternal infectious diseases, alcoholism, substance abuse
mothers with gestational diabetes
participation in another clinical study

The record

StatusCompleted

PhaseNo phase

Taking part159

StartedMay 2014

UpdatedAug 4, 2015

Conditions

Growth Tolerance Infant Development

Where10

Claude Ashley, MD
Dothan, Alabama, United States
JBRKIDS
Jonesboro, Arkansas, United States
Norwich Pediatric
Norwich, Connecticut, United States